IPCA Laboratories Limited — Others, 12-08-2025: Shareholders meeting

Ipca Laboratories' 75th Annual General Meeting concluded with shareholders approving all proposed resolutions. This includes the adoption of the financial results for the financial year ended March 31, 2025, and the confirmation of dividend payments. Additionally, shareholders approved the re-appointment of Directors Mr. Prashant Godha and Mr. Premchand Godha. Crucially, significant changes to the company's Memorandum of Association (MOA) and Articles of Association (AOA) were also approved. These amendments will impact the company's future business scope and internal governance framework, signifying strong shareholder confidence in the company's strategic direction.